Table 2.
Absolute and relative frequency distribution of subjects with vulvovaginal candidiasis according to complaints before and after treatment in the two treatment groups (fluconazole-placebo and fluconazole-protexin).
| Groups | Fluconazole + placebo | Fluconazole + protexin | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Complaints | Index | Intergroup comparison | |||||||||
| Before treatment | After treatment | Intergroup | Before treatment | After treatment | Intragroup | ||||||
| Total | Percent | Total | Percent | comparison | Total | Percent | Total | Percent | comparison | ||
| Vaginal secretion |
45 | 100 | 5 | 11.2 | — | 45 | 100 | 2 | 4.4 | — | NS Fisher |
| Itching | 45 | 100 | 7 | 15.6 | — | 45 | 100 | 7 | 15.6 | — | NS Chi-square |
| Dysuria | 23 | 51.1 | 12 | 26.7 | 0.001 | 21 | 46.7 | 4 | 8.9 | 0.001 | P = 0.02 |
| Pain during intercourse | 28 | 62.2 | 6 | 13.4 | 0.001 | 22 | 48.9 | 8 | 17.8 | 0.001 | NS Chi-square |
| Pain when urinating | 9 | 20 | 3 | 6.7 | 0.031 | 11 | 24.4 | 7 | 15.6 | 0.125 | NS Fisher |